Business / Finance

RSS
INTEGRA's innovative modules simplify magnetic bead purification workflows

INTEGRA's innovative modules simplify magnetic bead purification workflows

LabVantage’s Professional Services Organization Grows by More than 80% in Three Years and Expands Globally

LabVantage’s Professional Services Organization Grows by More than 80% in Three Years and Expands Globally

MIP Discovery closes £7M Series A financing to drive commercialization in cell and gene therapy space

MIP Discovery closes £7M Series A financing to drive commercialization in cell and gene therapy space

ARRALYZE® launches CellShepherd®: A fully autonomous single-cell platform for real-time monitoring of functional assays

ARRALYZE® launches CellShepherd®: A fully autonomous single-cell platform for real-time monitoring of functional assays

Aspen Biosciences launches Pipeline, the program management software platform specifically for drug discovery. The groundbreaking ‘Pipeline’ Platform is now available for therapeutics development teams

Aspen Biosciences launches Pipeline, the program management software platform specifically for drug discovery. The groundbreaking ‘Pipeline’ Platform is now available for therapeutics development teams

The MagBinder® Fit24 nucleic acid purification system

The MagBinder® Fit24 nucleic acid purification system

Bruker Acquires Spectral Instruments Imaging, the Performance Leader in Preclinical In-Vivo Optical Imaging Systems

Bruker Acquires Spectral Instruments Imaging, the Performance Leader in Preclinical In-Vivo Optical Imaging Systems

SLAS 2024 press release from Veranex

SLAS 2024 press release from Veranex

Revvity showcases cutting-edge solutions at SLAS2024

Revvity showcases cutting-edge solutions at SLAS2024

Asimov launches LV Edge Packaging System to optimize lentivirus production

Asimov launches LV Edge Packaging System to optimize lentivirus production

StemSight and ERS Genomics focus on collaboration

StemSight and ERS Genomics focus on collaboration

Evaluate, a Norstella company, announces acquisition of J+D Forecasting

Evaluate, a Norstella company, announces acquisition of J+D Forecasting

Universal Coronavirus vaccine could save billions in U.S., new study suggests

Universal Coronavirus vaccine could save billions in U.S., new study suggests

QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems

QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems

Marking a vital milestone for Vertex and Charles River

Marking a vital milestone for Vertex and Charles River

Cellular Origins, a TTP Company, establishes Advisory Board of global industry leaders

Cellular Origins, a TTP Company, establishes Advisory Board of global industry leaders

Inpatient costs of treating COVID-19 in the U.S.

Inpatient costs of treating COVID-19 in the U.S.

PharmaKure granted MHRA Clinical Trial Authorisation (CTA) for PK051 for the treatment of mild cognitive impairment due to Alzheimer’s Disease

PharmaKure granted MHRA Clinical Trial Authorisation (CTA) for PK051 for the treatment of mild cognitive impairment due to Alzheimer’s Disease

Sphere Fluidics appoints Dr. Graeme Daniels as Vice President of Sales and Marketing

Sphere Fluidics appoints Dr. Graeme Daniels as Vice President of Sales and Marketing

SolasCure demonstrates proof-of-concept in Phase lla safety trial of Aurase Wound Gel

SolasCure demonstrates proof-of-concept in Phase lla safety trial of Aurase Wound Gel

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.